Senzime Expands Pediatric Anesthesia Presence with New U.S. Hospital Contract
UPPSALA, Sweden, June 3, 2026 Senzime AB announced continued momentum in the pediatric anesthesia market with the award of...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
UPPSALA, Sweden, June 3, 2026 Senzime AB announced continued momentum in the pediatric anesthesia market with the award of...
WESTBOROUGH, MASSACHUSETTS, April 28, 2026 Olympus Corporation has received FDA 510(k) clearance for its latest innovation, the POWERSEAL™ Open...
AMSTERDAM, Netherlands, April 16, 2026 Royal Philips has announced a major advancement in medical imaging with the U.S. FDA...
NEW YORK, April 17, 2026 Intelligent Bio Solutions Inc. (INBS) has strengthened its upcoming FDA 510(k) submission by successfully...
PITTSBURGH, Pa., April 17, 2026 Xodus Medical, Inc. announced the launch of its Hot Pink Pad®, following FDA 510(k)...
NEW YORK, April 2, 2026 Intelligent Bio Solutions Inc. has achieved a critical milestone in its regulatory journey by...
SECAUCUS, N.J., Feb. 23, 2026 — The Vitamin Shoppe announced the launch of its inaugural “Suppies” Awards, a new...
TORONTO, Sept. 2, 2025 – Geneseeq Technology Inc. announced that its GeneseeqPrime® NGS Tumor Profiling Assay has received 510(k)...
